Lipella Pharmaceuticals Inc. (LIPO) stock
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Lipella Pharmaceuticals's total assets was $2.35M at Sep 30, 2025. For fiscal 2024 it was $2.67M, down 25.3% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.67M | -25.3% |
| FY2023 | Dec 31, 2023 | $3.58M | -39.9% |
| FY2022 | Dec 31, 2022 | $5.95M | +195.6% |
| FY2021 | Dec 31, 2021 | $2.01M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $2.35M | +8.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.72M | +70.3% |
| Q1 FY2025 | Mar 31, 2025 | $4.86M | +54.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.67M | -25.3% |
| Q3 FY2024 | Sep 30, 2024 | $2.16M | -24.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.18M | -37.4% |
| Q1 FY2024 | Mar 31, 2024 | $3.14M | -32.0% |
| Q4 FY2023 | Dec 31, 2023 | $3.58M | -39.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.84M | +41.1% |
| Q2 FY2023 | Jun 30, 2023 | $3.49M | – |
| Q1 FY2023 | Mar 31, 2023 | $4.61M | – |
| Q4 FY2022 | Dec 31, 2022 | $5.95M | – |
| Q4 FY2021 | Dec 31, 2021 | $2.01M | – |
See a number that looks wrong?